onartuzumab   Click here for help

GtoPdb Ligand ID: 8966

Synonyms: MetMAb | OA-5D5 | OA5D5 | PRO 143966
Compound class: Antibody
Comment: Onartuzumab is an investigational, humanized monoclonal antibody targeting the MET receptor tyrosine kinase, a proto-oncogene which acts as a hepatocyte growth factor receptor. The protein is a monovalent (single-armed) construct, as opposed to bi-valent intact antibody structures.
Peptide sequence information for this antibody is available from its IMGT/mAb-DB record.
BLAST peptide analysis reveals identical match with sequences deposited with patent US7615529 [4], which relate to the monoclonal isolated from hybridoma 5D5.11.6 therein.
Click here for help
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
9368 onartuzumab
Synonyms Click here for help
MetMAb | OA-5D5 | OA5D5 | PRO 143966
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 368
Other databases
GtoPdb PubChem SID 310264746
Search PubMed clinical trials onartuzumab
Search PubMed titles onartuzumab
Search PubMed titles/abstracts onartuzumab